CLDHF(CLDHF)
CLDHF
No analyst ratings available
No analyst price targets available for CLDHF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $217M | $221M | $214M |
| Low | $216M | $219M | $213M |
| High | $218M | $223M | $215M |
| EBITDA Avg | $121M | $123M | $119M |
| Low | $120M | $122M | $119M |
| High | $121M | $124M | $120M |
| EBIT Avg | $120M | $122M | $119M |
| Low | $120M | $121M | $118M |
| High | $121M | $124M | $119M |
| Net Income Avg | $48M | $50M | $42M |
| Low | $48M | $49M | $42M |
| High | $48M | $50M | $43M |
| EPS Avg | $0.04 | $0.04 | $0.03 |
| Low | $0.04 | $0.04 | $0.03 |
| High | $0.04 | $0.04 | $0.03 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $149M | $149M | $149M |
| Low | $149M | $149M | $149M |
| High | $149M | $149M | $149M |
| EBITDA Avg | $83M | $83M | $83M |
| Low | $83M | $83M | $83M |
| High | $83M | $83M | $83M |
| EBIT Avg | $82M | $82M | $82M |
| Low | $82M | $82M | $82M |
| High | $82M | $82M | $82M |
| Net Income Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| EPS Avg | — | — | — |
| Low | — | — | — |
| High | — | — | — |
| Analysts (Rev / EPS) | 1 / — | 1 / — | 1 / — |